Linzagolix choline | m-entrepreneurship.com

Product Name :
Linzagolix choline

Search keywords :
Linzagolix

drugId :
null

Target Vo:
Gonadotropin-releasing hormone receptor

Target Vo Short Name :
GnRHR

Moa_Name:
Gonadotropin-releasing hormone receptor antagonists

First Approval Country :
EU

First Approval Date Filter:
2022

Origin Company_Name :
Kissei Pharmaceutical Co Ltd

Active Company_Name :
Jw Pharmaceutical Corp

Active Indication_Name:
Leiomyoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cy7-conjugated AffiniPure Goat Anti-Rabbit IgG H&L Epigenetics
AMPK beta 1 Rabbit pAb manufacturer
RSK1 p90 Antibody (YA676): RSK1 p90 Antibody (YA676) is a non-conjugated and Mouse origined monoclonal antibody about 83 kDa, targeting to RSK1 p90 (6B9). It can be used for WB,IP assays with tag free, in the background of Human, Mouse, Monkey.

Author: Betaine hydrochloride

Related Posts